semaglutide mechanism difference Frontiers Amylin Receptor Agonist: Complete Guide

In the SUSTAIN 7 clinical trial, approximately 22% of Trulicity patients experienced nausea compared to 33 to 44% with Ozempic

10.1210/er.2018-00084 60

For instance, in the SUSTAIN-6 trial, semaglutide was associated with a significantly higher ratio of retinopathy complications compared with placebo, including vitreous hemorrhage, retinal photocoagulation, and intravitreal therapy

It's important to note that Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are FDA-approved for chronic weight management, while Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for type 2 diabetes management, though sometimes used off-label for weight loss